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In patients with heart failure, left ventricular systolic dysfunction and prolonged QRS
complex, cardiac resynchronization therapy (CRT) is a treatment method aimed at
restoration of myocardial depolarization synchronicity. However, the extent of clinical
and echocardiographic improvement depends on anatomical relations in individual
patients, on structural changes in the heart, on intrinsic electrical activation, and on the
position of pacing leads. Many parameters of CRT devices may be changed in order to tailor
the function of CRT to the needs of a particular patient; the most important among them is
AV and VV interval. The largest trials studying CRT used various methods for optimization
of these intervals but unequivocal proof of the beneﬁt brought by optimization is still
lacking. Many methods were evaluated, most frequently based on echocardiography and
intracardiac electrogram interval measurement. However, drawbacks in statistics make
the studies of limited value for establishing a reference method or guidance for daily
practice. Echocardiography has inherent variability of results and is highly operator
dependent. Optimization based on intracardiac electrogram intervals has not proved yet
to be of clear beneﬁt above arbitrary AV interval. The most promising method is
hemodynamic assessment by ﬁnger plethysmography. Measured data are highly reprodu-
cible and operator-independentA randomized multicenter double-blind study using ﬁnger
plethysmography is needed to prove the value of this method and of CRT optimization in
general. The measurement of information content in any data suitable for CRT optimiza-
tion, analysis of reproducibility and general usage of conﬁdence intervals may show other
methods appropriate for it, too. The cooperationwith a statistician is oftentimes a necessity.
& 2013 Published by Elsevier Urban & Partner Sp.z o.o. on behalf of The Czech Society of
Cardiology.
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Cardiac resynchronization therapy (CRT) has become one of the
fundamental therapeutic methods in patients with heart failure,
left ventricular dysfunction and QRS prolongation. The aim of
CRT is to restore ventricular electrical activation timing and thus
to improve left ventricular mechanical coordination. Unfortu-
nately, full restoration with CRT is not possible – an intact His-
Purkinje system cannot be completely substituted by anymeans.
CRT devices have several pacing intervals, AV and VV intervals
in particular, which may be optimized according to the indivi-
dual patients' needs. Individual patients may differ not only in
the intrinsic activation sequence and velocity but also in lead
location or in the distribution of scars after myocardial infarction,
which may require different AV and VV interval settings to
maximize the effect of resynchronization. The aforementioned
facts were probably well known to the authors of the largest
studies proving clinical effect of CRT: COMPANION [1,2] and
CARE-HF [3,4]. The pacing interval optimization was performed
in both of them. However, the optimization is difﬁcult in daily
clinical practice; it is time consuming and lacks any approved
standardized method. One can get a time estimate for optimiza-
tion from a study by Brignole who used tissue Doppler technique
for VV interval optimization and pointed out its relative simpli-
city. Time required for the optimization of this interval in one
patient was less than 60min [5]. But the wealth of methods
available for the measurement of the impact of pacing on
hemodynamics is really great.2. Invasive methods of CRT optimization
Only the maximum of the ﬁrst derivative of left ventricular
pressure (dP/dtmax) has reached broader acceptance. This
parameter serves as an index of contractility, unfortunately
not independent. The Frank–Starling law teaches us that
myocardial contractility is preload dependent, a Bowdich or
staircase phenomenon describes that contractility increases
with the heart rate, and ﬁnally, afterload increases contrac-
tility as well (Anrep effect). dP/dtmax is rarely used in clinical
practice [6]; its role is more in validation of other methods.
It is oftentimes measured with inductance catheters
together with stroke volume and other hemodynamic vari-
ables [7].3. Echocardiographic methods
of CRT optimization
3.1. Methods using the mitral inﬂow pattern
The aim is to set the AV delay so that the untruncated A wave
ends in the moment of mitral valve closure. The most
straightforward way is to search for it by iterative changes
in the AV delay under echocardiographic guidance (iterative
method). To reach the same goal just from the measurements
during two AV delays, from a “too long” AV delay and a “too
short” AV delay, Ritter's method can be used. It was devel-
oped in patients with dual chamber pacemakers and pub-
lished as an abstract in 1994 [8]. Optimal AV delay (AVopt) is
calculated according to the equation
AVopt ¼AVlong–ðQAshort þQAlongÞ
where QAshort stands for the interval between the QRS onset
and the end of A wave during pacing with “short” AV delay
(this interval represents approximately the delay between
electrical and mechanical systole). Then, during pacing with
“long” AV delay (AVlong) QAlong represents the interval between
mitral valve closure and the QRS onset. The sum of QAshort+-
QAlong is subtracted from AVlong and the result is AVopt (Fig. 1).
Another way to calculate optimal AV delay in patients with
systolicmitral regurgitationwithout time consuming iteration
was published by Meluzin [9]. First step is to measure the
longest AV delaywith full ventricular capture. Then, this value
is decreased by 5–10 ms to so called “testing long AV delay”,
and the time interval from the end of the A wave to the onset
of the systolic component of mitral regurgitation (time t1) is
measured at this setting. The optimal AV delay is calculated as
“testing long AV delay”−time t1 (Fig. 2).
3.2. Methods quantifying the aortic outﬂow
or mitral inﬂow
Blood ﬂow through the left ventricular outﬂow tract (LVOT)
during one cardiac cycle can be measured using velocity–time
integral (VTI). VTI in LVOT (VTIao) is frequently used as a
surrogate for stroke volume [10]. The aim of the optimization
is to reach the largest area under the curve which indicates
the highest stroke volume. The method is used not only for







Fig. 2 – Meluzin's method for AV delay optimization. A – A
wave, E – E wave, sMR – systolic mitral regurgitation, t1 –
time interval between the end of A wave and the onset of
mitral regurgitation (adapted from Meluzin [9]).
Fig. 3 – Measurement of time–velocity integral of the ﬂow in
the left ventricular outﬂow tract (VTIao) obtained by Doppler
echocardiography. Time–velocity integral – the area under
the curve of a Doppler signal in the left ventricular outﬂow
tract (VTIao). (Figure by courtesy of Dr. Lhotsky).
Fig. 1 – Ritter's method for AV optimization: AVlong – long AV
delay, AVopt – optimal AV delay, QAshort – interval between
QRS onset and the trimmed end of A wave, QAlong – interval
between the end of A wave and the onset of QRS, E – E wave,
A – A wave, S – beginning of mechanical systole (the
moment of mitral valve closure). (Adapted from Melzer [63]).
c o r e t v a s a 5 5 ( 2 0 1 3 ) e 4 0 3 – e 4 1 0 e405VTI in the mitral inﬂow region is used for optimization
less frequently [11].
3.3. Methods for quantiﬁcation of dyssynchrony
The main goal of resynchronization is to restore mechanical
synchrony of contraction between left ventricular septum
and the free wall. The VV interval can be optimized accordingto the left ventricular lead location and the speed of the
mechanical contraction wave. The dyssynchrony measure-
ment is mostly based on tissue Doppler techniques (TDI). Jose
Brugada and his group published a study using the compar-
ison between septum and lateral wall in apical four-chamber
view and between anterior and inferior wall in apical dual-
chamber view [12]. Another group optimized VV interval by
measuring dyssynchrony in 6 basal segments [5]. Speckle
tracking is a newer method with similar goals using different
principle to visualize mechanical activity of the ventricular
myocardium. The use for CRT optimization was published
only in individual patients [13]. Three-dimensional (3D)
echocardiography has rarely been used for optimization so
far [14].
3.4. Tei-index
Tei-index (myocardial performance index – MPI) is a para-
meter of heart function, which is relatively easy to measure.
It is calculated according to the equation [(isovolumic
contraction time+isovolumic relaxation time)/ejection time].
It was used rarely for CRT optimization [15,16].
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4.1. Non-invasive cardiac output measurement
Much effort has been made to measure cardiac output using
methods less invasive and less demanding than Fick princi-
ple, dye-dilution or thermodilution. Semi-invasive system
LiDCO calculates beat to beat changes of stroke volume from
the arterial pulse wave obtained using an arterial cannula.
For absolute values, the system must be calibrated by apply-
ing lithium chloride intravenously. The system was used for
CRT optimization only rarely [17].
Another option for fully noninvasive cardiac output mea-
surement is bioimpedance. For CRT optimization, Task Force
Monitor (CNSystems, Graz, Austria) [18–20], BioZ (CardioDy-
namics, San Diego, USA) [21] or NICOM (Cheetah Medical,
Vancouver, USA) [22] were used.
Different principle is applied in the Innocor system (Inno-
vision, Odense, Denmark). The device measures the changes
in concentration of two inert gases during short-term
rebreathing. The rebreathing bag is preﬁlled with an O2
enriched mixture typically containing 0.5% nitrous oxide
(N2O) which is blood soluble and 0.1% sulfur hexaﬂuoride
(SF6) which is blood insoluble. The concentration change of
SF6 during rebreathing is measured to determine the lung
volume and to account for other factors that affect the
distribution of the blood soluble gas. The diminishing con-
centration of N2O during rebreathing reﬂects the blood ﬂow
through the lungs. When there are no AV shunts the blood
ﬂow through the lungs equals cardiac output. Several studies
used this method for CRT optimization [23–25].
4.2. Noninvasive blood pressure measurement
Beat to beat measurement of blood pressure changes is
usually based on ﬁnger plethysmography. The fundamental
principles were developed by Prof. Peňáz (Brno, Czech Repub-
lic). CRT optimization was performed using Finometer (FMS
Amsterdam, The Netherlands) and Nexﬁn (BMEYE, Amster-
dam, The Netherlands) [26,27].
4.3. Acoustic cardiography
Acoustic cardiography is based on the measurement of the
time interval between the QRS onset and mitral component
of the ﬁrst sound. CRT optimization was mostly done with
AUDICOR TS (Inovise Medical, Beaverton, USA) [28–31]. The
same principle was used in the study by Miki; the micro-
phone was connected to the audio input of the echocardio-
graphic machine [32]. Similar principle was applied in sonR –
a sensor commercially available for optimization in the CRT
devices from Sorin Group [33].
4.4. Methods based on the ECG or intracardiac
ECG analysis
The most simple method for VV interval optimization is
based on the QRS complex duration measurement [34–36];
experience with morphological criteria is limited [37]. Baroldand his group published a study, where the VV interval was
set according to the latency of pacing from both right
ventricular and left ventricular leads [38].
Methods based on intracardiac ECG (IEGM) interval mea-
surement have an advantage in easy incorporation into the
CRT devices. QuickOpt algorithm (St. Jude Medical) uses atrial
depolarization duration measured in the RV lead for the AV
delay calculation. SensedAVdelay equals atrial depolarization
duration plus speciﬁc increment that depends on the duration
of atrial depolarization. If it is ≥100 ms the algorithm adds
30 ms; if it is o100 ms the algorithm adds 60 ms. In case of
atrial pacing instead of sensing, another 50 ms are added to the
AV delay. VV interval is calculated according to the equation
ðVV¼ 0:5ðΔþ εÞ
where Δ¼RLV–RRV (RLV and RRV stands for local activation
detected by LV or RV lead), and ε¼plVCDLR–plVCDRL, (plVCDLR
is the interval between the pace in LV to the sense in the RV
lead whereas plVCDRL is the interval between RV pace and LV
sense) [39–43].
SmartDelay (Boston Scientiﬁc) calculates the AV delay
during atrial sensing (SAVD) or atrial pacing (PAVD) as follows:
SAVD¼K1QRSþ K2 SAVIþ K3
PAVD¼K1QRSþ K2 PAVIþ K3
where SAVI and PAVI are intervals between sensing (SAVI) or
pacing (PAVI) in the atrium and sensing in the RV; K1, K2 and
K3 are coefﬁcients taking the lead location into account –
details and experimental testing of the algorithm were
described in detail by Gold [44].
The aCRT algorithm (Medtronic) periodically updates
intrinsic AV interval, determined as the time from the atrial
sensing or pacing to the RV sensing, P-wave conduction
interval, determined as the time from atrial sensing or pacing
to the end of the P wave in the far-ﬁeld electrogram, and QRS
conduction interval determined as the time from the RV
sensing to the end of the QRS complex in the far-ﬁeld
electrogram. If the intrinsic AV interval during atrial sensing
is normal (≤200 ms) and the heart rate does not exceed 100/
min, the algorithm uses only LV pacing with preempt intrin-
sic conduction by at least ≥40 ms. Otherwise, the algorithm
switches to biventricular pacing with the AV delay calculated
from the intrinsic A-RV to pace after the completion of the P
wave but to preempt intrinsic RV sensing by at least 50 ms. V–
V interval is calculated from the QRS duration. Basic princi-
ples were published by Krum [45].5. Clinical signiﬁcance of pacing intervals
optimization
The aforementioned list of methods, which is far from being
complete, documents the effort which was invested into
pacing interval optimization. But is there any evidence about
the beneﬁt brought by optimization? Very few multicentric
randomized double blind studies were published. Sawhney in
2004 in an unicentric randomized controlled single blinded
study showed that AV optimization with VTIao improved
LVEF, NYHA class and quality of life after 3 months of follow-
up when compared with empiric AV delay at 120 ms [46].
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trial – a multicentric double-blind study in 980 patients
randomized to either empirical AV delay of 120 ms, to AV
delay optimized according to the mitral inﬂow pattern (itera-
tive method) or to the SmartDelay algorithm. Primary end-
point was the change in left ventricular endsystolic volume
(LVESV), secondary endpoints were the change in NYHA
class, quality of life, 6-min walking test and left ventricular
enddiastolic volume of the left ventricle. Optimization did not
improve any of the endpoints in the optimized arm above the
results of the empiric AV delay arm [47,48].
FREEDOM trial was a multicentric randomized prospective
double blind study with the hypothesis that frequent AV and
VV optimization using QuickOpt is better or is not worse than
empiric AV delay or AV delay optimized by some other
method not based on IEGM. The results were presented by
Abraham at HRS Meeting 2010 and are available after regis-
tration on the web pages of St. Jude Medical. The trial
randomized 1525 patients either to QuickOpt algorithm or
to the control group where either empiric AV delay was
programmed (470 persons) or optimization was performed
only at the beginning of the study (274 persons). After 12
months of follow-up, no signiﬁcant difference between
groups could be found [49].
Multicenter randomized studies limited only on VV opti-
mization are rare. RHYTHM II ICD trial was multicentric
single-blinded study in 121 patients with AV delay optimiza-
tion using the pattern of mitral inﬂow who were randomized
in 3:1 ratio to the VV optimization using VTIao or simulta-
neous ventricular pacing. After 6 months of follow-up, no
difference in reverse remodeling between both groups was
observed [50,51].
Rao in 2007 published results of DECREASE-HF which was
a multicentric randomized double-blind study with 306
patients who were implanted with Contak Renewal 2/4/4HE
and randomized either to simultaneous biventricular pacing
or to sequential biventricular pacing or LV pacing only. The
optimization was performed using the algorithm ExpertEase
implemented in the device. Patients with sequential ventri-
cular pacing had LV preexcitation in the range 20–80 ms, and
individual intervals were selected according to the algorithm
based on IEMG intervals which was developed on hemody-
namic data from PATH-CHF. After 3 and 6 months of follow-
up, stroke volume and ejection fraction increased in all
groups. The decrease in LVESV was most pronounced in the
group with simultaneous biventricular pacing [52].
A multicetric, randomized, double-blind noninferiority
Adaptive CRT Study evaluated the aCRT algorithm. It
included 522 patients who were randomized in 2:1 ratio to
the aCRT algorithm or to the optimization using echocardio-
graphic parameters – the iterative method for AV delay and
VTIao for VV interval. There were three endpoints: clinical
composite score (CCS) used in multiple CRT trials reﬂecting
overall course of the disease (death, hospitalization for heart
failure or worsening of heart failure); concordance correlation
coefﬁcient between VTIao and aCRT algorithm; safety of a
CRT algorithm. During 6 months of follow-up, all three
primary objectives were met [53].
Another small unicentric double-blind crossover study
included 24 patients who were optimized using Innocor.Optimal pacing intervals signiﬁcantly increased exercise
tolerance [23].
The aforementioned data show that methodically strict
studies do not unequivocally prove the beneﬁt from CRT
optimization. However, the number of studies is limited and
majority of them delt with IEGM based algorithms incorpo-
rated in CRT devices.6. The comparison of the most frequently
used optimization methods
The algorithms implemented into the CRT devices are quite
easy to access and use. SmartDelay in SMART-AV was shown
to be as good as empiric AV delay of 120 ms. QuickOpt
algorithm was very promising in the beginning. Baker found
very good correlation between this algorithm and VTIao
[54]. In another study, very good concordance between this
algorithm and 3D echo was found [39]. An agreement with
the results of this algorithm and other echocardiographic
methods was achieved in several studies [40,55]. However,
FREEDOM trial has cast some shadow on this algorithm [49].
Second place in the frequency of use belongs to echocar-
diographic methods. The most simple may appear to be
Ritter's method. Limitations can be in the difﬁculty to ﬁnd
the exact end of the A wave; frequently at least limited
iteration is necessary. A fundamental problem is that the
mitral wave closure at the end of A wave does not correlate
with the highest dP/dtmax in the left ventricle, it is usually
close to the top of A wave [56].
VTIao is not free of problems either. Whereas Thomas in
his study says that “Left ventricular outﬂow tract VTI pro-
vides us with a single, direct measure of global LV function
which is robust, and easily applicable in routine clinical
practice, and which is effective at improving response to
CRT” [57], Zuber ﬁnds the reproducibility of VTI very limited
[31]. High variability in results was found by Whinnett as well
[58]. In one study, mathematical modeling based on pub-
lished data from another study showed that utility of VTIao
for CRT optimization might be limited [59].7. What to do in daily practice?
Two problems must be taken into account when we think
about the optimization methods. First, the human body
represents a system inclined to equilibrium. Francis' group
which published a series of papers about ﬁnger plethysmo-
graphy optimization demonstrated that blood pressure
change accompanying the pacing parameters change is only
temporary [60,61].
Second, we should be aware of the limitations of a
particular method. This concept developed by Francis oper-
ates with the term of information content. Every measured
parameter has some random noise and some information.
The proportion of the information in the signal is the
information content (range 0–1):
information content¼ signal varianceðsignal varianceÞ þ ðnoise varianceÞ





Information content can be measured in every lab using
repeated measurements. To give an example, let us imagine
that we optimize AV delay. We perform 4 measurements with
AV delay at 100 ms, 4 measurements with AV at 120 ms and 4
measurements with the AV delay at AV 140 ms. Information








where R is the number of repetitions (R¼4 in our hypothetical
measurement), Vraw is the variance for all data, i.e. for 12
values from their mean and Vm is the variance of the means
for every AV delay (3 means, i.e. for 100, for 120 and for
140 ms) from the mean of these means (which is the same as
the mean of all 12 values). In this particular case, the
calculation will be based not on the absolute blood pressure
values measured during pacing with AV delays at 100, 120
and 140 ms on but the difference of systolic blood pressure
between arbitrarily selected reference AV delay, let’s say 160
ms, and the value under examination (100, 120 and 140 ms) as
explained below.
It is difﬁcult to deﬁne the minimum value of information
content for meaningful measurement. Simplifying the situa-
tion as much as possible, one could conclude that for AV delay
optimization, the information content below 0.4 makes the
measurement useless even with a clinically feasible number of
repetitions [59]. Provided we have some data obtained from
repeated measurements, validation of the signiﬁcance can be
done using conﬁdence intervals (CI). The CI of 95% is calcu-
lated as mean71.96 standard deviation (SD). SD is just a
square root of the above mentioned variation.
A meaningful procedure can be accomplished only using
methods with proven reliability. Assessment of the methods
based on visual analysis of a signal, like Doppler recordings or
QRS complex duration measurements, must therefore be done
blindly to quantify the information content correctly. Opera-
tor-independent methods (e.g. automated device measure-
ments) should reach stable information content when
meticulously applied. Finger plethysmography is the most
extensively investigated method so far. After series of studies,
Francis' group came to the conclusion that the best parameter
for CRT optimization is systolic blood pressure, followed by
pulse pressure and mean arterial pressure [62]. Because of
spontaneous ﬂuctuations in physiologic parameters, only the
differences of values caused by a change in parameters like
the change in blood pressure between randomly selected
reference AV delay and evaluated AV delay can be used. Last
six cycles before and immediately after parameter change
should be used for calculation, even better but rather demand-
ing is respiration cycle synchronization [59]. Adherence to
these rules provides reliable and reproducible data. Obviously,
all signal-processing issues of proper optimization based on
ﬁnger plethysmography can only be implemented with the
help of automatic or semiautomatic computer algorithms. The
validation of preliminary results in independent studies is
necessary prior to development of commercially availableoptimization systems. Unlike ﬁnger plethysmography, most
reports on other optimization methods published so far did
not meet the requirements of statistical veriﬁcation which
would prove their reliability. A multidisciplinary approach
with a statistician on board is essential for introducing new
optimization strategies into clinical practice.Acknowledgments
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